266 related articles for article (PubMed ID: 21841290)
1. Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.
Peña-Orellana M; Hernández-Viver A; Caraballo-Correa G; Albizu-García CE
J Health Care Poor Underserved; 2011 Aug; 22(3):962-82. PubMed ID: 21841290
[TBL] [Abstract][Full Text] [Related]
2. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
3. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
4. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
6. HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions.
Roux P; Sagaon-Teyssier L; Lions C; Fugon L; Verger P; Carrieri MP
BMJ Open; 2014 Oct; 4(10):e005694. PubMed ID: 25331969
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
[TBL] [Abstract][Full Text] [Related]
8. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis.
Vescio MF; Longo B; Babudieri S; Starnini G; Carbonara S; Rezza G; Monarca R
J Epidemiol Community Health; 2008 Apr; 62(4):305-13. PubMed ID: 18339822
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
10. High-risk drug-use practices among a large sample of Australian prisoners.
Kinner SA; Jenkinson R; Gouillou M; Milloy MJ
Drug Alcohol Depend; 2012 Nov; 126(1-2):156-60. PubMed ID: 22658284
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.
Reyes JC; Colón HM; Robles RR; Rios E; Matos TD; Negrón J; Marrero CA; Calderón JM; Shepard E
J Urban Health; 2006 Nov; 83(6):1105-13. PubMed ID: 17075726
[TBL] [Abstract][Full Text] [Related]
13. Violence and hepatitis C transmission in prison-A modified social ecological model.
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L
PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of hepatitis C virus infection among injecting drug users in Tehran.
Zamani S; Ichikawa S; Nassirimanesh B; Vazirian M; Ichikawa K; Gouya MM; Afshar P; Ono-Kihara M; Ravari SM; Kihara M
Int J Drug Policy; 2007 Oct; 18(5):359-63. PubMed ID: 17854723
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
16. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of hepatitis C virus among prisoners in Scotland.
Taylor A; Munro A; Allen E; Dunleavy K; Cameron S; Miller L; Hickman M
Addiction; 2013 Jul; 108(7):1296-304. PubMed ID: 23297816
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates.
Moazen B; Saeedi Moghaddam S; Silbernagl MA; Lotfizadeh M; Bosworth RJ; Alammehrjerdi Z; Kinner SA; Wirtz AL; Bärnighausen TW; Stöver HJ; Dolan KA
Epidemiol Rev; 2018 Jun; 40(1):58-69. PubMed ID: 29860343
[TBL] [Abstract][Full Text] [Related]
19. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
